These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20819983)

  • 21. Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.
    Granholm E; Holden JL; Sommerfeld D; Rufener C; Perivoliotis D; Mueser K; Aarons GA
    Trials; 2015 Sep; 16():438. PubMed ID: 26424639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R; Millet B; Herman E; Banki CM; Lublin H; Pans M; Hanssens L; L'Italien G; McQuade RD; Beuzen JN
    Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial.
    Jakubovski E; Carlson JP; Bloch MH
    J Clin Psychiatry; 2015 Nov; 76(11):1535-45. PubMed ID: 26581028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
    Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
    J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group.
    Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Ulrich RF; Carter M
    Arch Gen Psychiatry; 1991 Apr; 48(4):340-7. PubMed ID: 1672589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up.
    Zheng Y; Ning Y; She S; Deng Y; Chen Y; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Wu C
    Psychopathology; 2018; 51(3):167-176. PubMed ID: 29444522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation.
    Cai Y; Gong W; He W; He H; Hughes JP; Simoni J; Xiao S; Gloyd S; Lin M; Deng X; Liang Z; Dai B; Liao J; Hao Y; Xu DR
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e33628. PubMed ID: 35438649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion.
    Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Javna CD; Madonia MJ
    Arch Gen Psychiatry; 1986 Jul; 43(7):633-42. PubMed ID: 2872870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial treatments in schizophrenia: a review of the past 20 years.
    Huxley NA; Rendall M; Sederer L
    J Nerv Ment Dis; 2000 Apr; 188(4):187-201. PubMed ID: 10789995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
    Swartz MS; Perkins DO; Stroup TS; Davis SM; Capuano G; Rosenheck RA; Reimherr F; McGee MF; Keefe RS; McEvoy JP; Hsiao JK; Lieberman JA;
    Am J Psychiatry; 2007 Mar; 164(3):428-36. PubMed ID: 17329467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the impact of a psycho-educational intervention for people diagnosed with schizophrenia and their primary caregivers in Jordan: a randomized controlled trial.
    Hasan AA; Callaghan P; Lymn JS
    BMC Psychiatry; 2015 Apr; 15():72. PubMed ID: 25885432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The feasibility of cognitive adaptation training for outpatients with schizophrenia in integrated treatment.
    Hansen JP; Østergaard B; Nordentoft M; Hounsgaard L
    Community Ment Health J; 2013 Dec; 49(6):630-5. PubMed ID: 23064969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study.
    Liu Y; Yang X; Gillespie A; Guo Z; Ma Y; Chen R; Li Z
    Psychiatry Res; 2019 Feb; 272():275-283. PubMed ID: 30594760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study.
    Guo X; Zhang Z; Zhai J; Fang M; Hu M; Wu R; Liu Z; Zhao J;
    Compr Psychiatry; 2012 Oct; 53(7):1006-12. PubMed ID: 22516246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
    Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
    Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.